Eli Lilly Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,075

+0.4%

3:43 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DT who wrote (282)	7/28/1998 2:48:00 PM
From: Henry Niman	of 642

The news about Rezulin associated deaths was widespread. The LLY deal with LGND could significantly impact the oral diabetes market when trials progress. I have updated the diabetes page at home.att.net with links to reviews on Rexinoids and TZDs (in Signals Magazine and Business Week Online) as well as new diabetes treatments, including Rexinoids and TZDs, in NY Times and Diabetes Wellness Magazine.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next